Anne Moen is full professor at the Faculty of Medicine, University of Oslo, Oslo, Norway, and adjunct Professor, Norwegian Center for eHealth Research, Tromsø, Norway. She is Director of UiO:eColab, a research lab supporting technology mediated complex, patient focused interventions, and multidisciplinary teamwork where health professionals, patients and their families can collaborate to sustain health and wellbeing. Her program of research seeks to understand

digital citizens centered services, based on opportunities to “collect, curate and control” all relevant, personal health information. To do so, she combines in-depth insights in healthcare with design and deployment of accessible digital solutions, emphasizing citizen empowerment, digital health literacy and overall engagement for health and wellness.

Professor Moen is the Academic Coordinator of “Gravitate – Health: Empowering and Equipping Europeans with Health Information from trusted sources for active, safe, secure personal health management and adherence to treatment” Innovation Medicine Initiative Public-Private Partnership (project 945334, IMI2 JU, 2020-2026). Gravitate-Health’s mission is to prepare and test innovative, easy-to-use, elegant digital services that actively engage and empower citizens and their support network with access to and understanding of health information from trusted sources. More information is available at www.gravitatehealth.eu

Professor Moen was President of EFMI (European Federation for Medical Informatics) (2014 – 2016), IMIA-EFMI Regional Vice President (2016-2018) and EFMI representative in EU eHealth stakeholder group (2015 – 2019) assuming the role as rapporteur for exploration of “Citizens – health data”. She served as Board Chair, HL7 Europe (2023-2024), member of the HL7 Europe Board of Directors (2022-2024) and member of the HL7 Vulcan Accelerator Steering Committee (2022 – 2024). She is fellow of ACMI (American College of Medical Informatics) 2015, founding fellow of IAHSI (International Academy for Health Sciences Informatics) 2017, and elected Honorary Fellow of EFMI from 2019.

Anne Moen is an RN (1985), holds a master’s degree in nursing science (1996), and PhD in social sciences (Dr. polit) – specialization in health informatics (2002) from University of Oslo, Norway. She was Fulbright fellow (2002) and postdoc at University of Wisconsin-Madison and University of Oslo (2002 – 2005), continued as visiting research scientist at University of Wisconsin-Madison – Health systems Lab (Patricia F. Brennan PI) (2005 – 2012, 2015).

Over 20 years of experience in health informatics and IT project leadership, including 16 years as CEO of Felleskatalogen AS.​

Responsible for strategic, financial, and operational management, as well as external communication with authorities, healthcare professionals, and academia.​

Led key digital initiatives such as mobile apps, adverse reaction tools, clinical decision support systems, and digitized package leaflets.​

Actively involved in the Gravitate Health project, representing Nordic compendia and contributing FHIR ePIs for international test scenarios.​

Currently pursuing a Master’s degree in Health Informatics at NTNU to further strengthen expertise in digital healthcare solutions.​

Beverly Buckta has been an active HL7 participant throughout her career and has been involved in most FHIR accelerators, especially Vulcan. She currently leads Standards and Interoperability in the Medical Evidence Development-RWE Activation team at Pfizer within the Chief Medical Office. Bev first joined Pfizer as Director, Information Architecture Services within the R＆D Business Technology and Insights group responsible for driving R＆D architecture services that support data access and reuse of internal and external data sources. Bev began the Health IT program at Pfizer and was positioned within Digital to support all therapeutic areas prior to joining the Real World Evidence Center of Excellence in Mar 2021 as a leader in Strategy, Innovation, and Partnerships. Beverly has had an extensive history in establishing and leading global Information Management and Enterprise Architecture programs in the Pharmaceutical Industry.

Prior to joining Pfizer, Beverly was the Global Principal Information Architecture Lead at AstraZeneca (AZ) and led knowledge management initiatives at Bristol-Myers Squibb across R&D, Operations, M&S, and Enabling Functions. Bev’s career began with
Cytogenetic Research at Robert Wood Johnson University Hospital and Medical School.

In 1995, Dr. Alper founded DynaMed, an evidence-based clinical reference, with the mission to provide the most useful information to health care professionals at the point-of-care. Dr. Alper’s mission expanded to provide the most useful support for healthcare decision making. Dr. Alper has advanced evidence-based medicine methods through systems to support rapid development of high-quality guidelines with limited resources (RAPADAPTE), modernized models to organize evidence and guidance for searches for clinical use (EBHC Pyramid 5.0), and defined certainty of net benefit as a focal point for what matters in healthcare decision making. In 2019, Dr. Alper developed a novel method to evaluate inconsistency across clinical practice guidelines.

In 2018, Dr. Alper started extending the HL7® FHIR® standard for computable and interoperable expression of evidence and statistics (EBMonFHIR project). Pandemic-level demands for knowledge support led Dr. Alper to change his lifetime mission to enable standard-based machine-interpretable expression of knowledge, especially related to healthcare and scientific evidence. This has led to creating Computable Publishing LLC (a for-profit company to create supporting technology), Scientific Knowledge Accelerator Foundation (a non-profit charity), Health Evidence Knowledge Accelerator (open virtual meetings with 10+ working groups), Evidence Based Medicine on FHIR Implementation Guide (covering original research, evidence synthesis, and guideline development), Scientific Evidence Code System (terminology for study design, risk of bias, and statistics), and the FEvIR Platform (system to facilitate data exchange for scientific knowledge).

Chris Decker is President and CEO of CDISC. Widely recognized in the industry, Chris has decades of experience leveraging technology and standards to optimize processes and help industry drive innovation forward. He has extensive experience in executive roles across software development, clinical research, and consulting and his 20-year engagement with CDISC includes roles as a volunteer, implementer, and board member. Chris is passionate about leading CDISC towards a technology-based standards future and expanding the organization's global impact in clinical research standards.

Chris Price has over twenty years’ experience in the pharmaceutical industry leading projects relating to tools, systems, process and mindsets. He has spent many years leading the design and governance of biomedical data standards as well as consulting across the organisation on the implementation of these data standards and how metadata can drive automation. Additionally, Chris is the Working Groups Director at PHUSE responsible for the non-competitive, collaborative framework discussing topics and solutions relating to the advancement of computational science in medical research.

Dr. Chute is the Bloomberg Distinguished Professor of Health Informatics, Professor of Medicine, Public Health, and Nursing at Johns Hopkins University, and Chief Research Information Officer for Johns Hopkins Medicine.

He is also Deputy Director of the Institute for Clinical and Translational Research and Director, WHO Collaborating Centre for Classifications, Terminologies and Standards. He received his undergraduate and medical training at Brown University, internal medicine residency at Dartmouth, and doctoral training in Epidemiology and Biostatistics at Harvard. He is Board Certified in Internal Medicine and Clinical Informatics, and an elected Fellow of the American College of Physicians, the American College of Epidemiology, HL7, the American Medical Informatics Association, and the American College of Medical Informatics (ACMI), as well as a Founding Fellow of the International Academy of Health Sciences Informatics; he was president of ACMI 2017-18. We became a distinguished Fellow of ACMI in 2022. He is an elected member of the Association of American Physicians and the National Academy of Medicine. He received the highest distinction in biomedical informatics, the Morris Collen Award of Excellence from ACMI in 2025.

His career has focused on how we can represent clinical information to support analyses and inferencing, including comparative effectiveness analyses, decision support, best evidence discovery, and translational research. He has had a deep interest in the semantic consistency of health data, harmonized information models, and ontology. His current research focuses on how we classify dysfunctional phenotypes (disease) and the harmonization and rendering of real-world clinical data including electronic health records to support a learning health system. He became founding Chair of Biomedical Informatics at Mayo Clinic in 1988, retiring from Mayo in 2014, where he remains an emeritus Professor of Biomedical Informatics. He is presently a PI on a spectrum of high-profile informatics grants from NIH spanning translational science including co-lead on the National COVID Cohort Collaborative (N3C). He has been active on many HIT standards efforts and chaired ISO Technical Committee 215 on Health Informatics and chaired the World Health Organization (WHO) International Classification of Disease Revision (ICD-11).

Professor Dipak Kalra is President of The European Institute for Innovation through Health Data (www.i-hd.eu), a Professor of Health Informatics and a former London general practitioner. He plays a leading international role in Electronic Health Record R&D, including the reuse of EHRs for research. He has led the development of ISO standards on EHR interoperability, personal health records and data protection.

He participates in multiple European Commission funded projects including support for the accelerated uptake of digital health innovations, scaling up the quality, interoperability and the reuse of health data for research including inputs to the European Health Data Space, the collection and use of health outcomes towards more value-based care, the development of an AI-powered federated learning platform in lung cancer and initiatives to improve a patient’s understanding of their medication to improve confidence and adherence.

Hisashi Osanai is a Senior Manager at Fujitsu, specializing in healthcare data utilization. Confronted with poorly maintained and underutilized data in Japanese medical institutions, he actively promotes data standardization through FHIR and contributes to the FHIR Japanese Implementation Research Working Group. Beyond clinical settings, Hisashi is committed to advancing the standardization of Personal Health Records (PHR) using FHIR.

He also plays a key role in the PHR Service Business Association, fostering collaboration and innovation to ensure interoperability and secure data exchange. His dual focus on institutional and personal health data interoperability represents a major contribution to improving Japan’s healthcare ecosystem.

Dr. Maryam Garza is an Associate Professor and Researcher at the University of Texas Health Science Center at San Antonio (UTHealth San Antonio) one of HL7® Vulcan’s founding member sites. Dr. Garza has over 10 years of experience in clinical research and public health informatics and her areas of focus include healthcare data standards, secondary use of electronic health record (EHR) data for clinical and public health research, data quality, and interoperability and healthcare information exchange.

Throughout her career, she has worked in both an operational capacity (offering data management and informatics support) and a research capacity (as a primary or coinvestigator) on national and international, single- and multi-site studies. As the need for data is not unique to any one clinical domain, she has had the opportunity to work on studies across a wide variety of therapeutic areas, with most of her work having been in cardiology, trauma, aging and brain health, mental health, pediatrics/neonatology, and rare diseases. She has committed herself to the broader informatics and data standards communities at large through her long-term engagement with HL7®. She has been an active, voting member of HL7® since 2012, participating in several working groups over her tenure. In 2022, she was elected as one of the Co-Chairs of the BR&R work group and, in that same year, as one of the Co-Chairs for the Vulcan Operations Committee, and she continues in those roles today.

Michael Buckley (Mike) has served as CRIT’s Associate Director of Product Management since October 2022. In this role, he leads diverse teams who translate user needs into transformative digital products that improve the quality, cost, and experience of healthcare for MSK clinical research customers.

Michael joined MSK in 2008. He served as the Manager of Enterprise Clinical Research Innovation (2014-2022) and, earlier, as Manager of the Department of Medicine Clinical Trials Office. Prior to joining MSK, Michael was Associate Research Scientist and Manager of the Clinical Core Laboratories of The NYU School of Medicine’s Cancer Institute, which included the radiochemistry, pharmacokinetics, and pharmacodynamics core facilities.

Michael holds a BS in Chemistry from Allegheny College, an MS in Biology from NYU, and an MBA, with a specialization in high technology, from Northeastern University. With more than 20 years of experience in oncology research, he is also the Co-Founder and Co-Chair, of the Society for Clinical Data Management’s eSource Implementation Consortium.

Dr. Mohammad Adibuzzaman is an Assistant Professor and Director of Informatics at Oregon Health & Science University (OHSU). He leads the Informatics Program at the Oregon Clinical and Translational Research Institute (OCTRI), where he oversees research data strategy, AI governance, and research infrastructure under OHSU’s NIH Clinical and Translational Science Award. Trained in computer science and computational sciences at the Bangladesh University of Engineering and Technology and Marquette University, Dr. Adibuzzaman’s research focuses on causal inference, algorithmic fairness, and scalable computing for health data analytics. Nationally, he co-chairs the CTSA Working Group on the Principles of AI Translation in Healthcare (PATH), advancing national frameworks for trustworthy, explainable, and equitable AI in medicine.

Dr. Feliciano “Pele” Yu, Jr., is a pediatrician with expertise in clinical informatics and health services research. He made significant contributions to the advancement of clinical informatics nationally as well as in healthcare interoperability standards development efforts. He is the Chief Medical Information Officer at Arkansas Children’s Hospital and Professor of Pediatrics, Biomedical Informatics and Public Health at the University of Arkansas for Medical Sciences College of Medicine. He maintains clinical practice at Arkansas Children’s Hospital Pediatric Integrative Health Clinic.

Rich is responsible for developing and executing The ALS Association’s federal advocacy agenda and leading outreach efforts with federal agencies and the White House to influence federal actions on issues that matter to people living with ALS. Rich has over 20 years of federal advocacy experience as a health policy expert and lobbyist who works with the White House, federal agencies, and Congress on innovating health care. He has successfully advocated for federal initiatives and laws by mobilizing patient grassroots advocacy and comprehensive government affairs strategies. His efforts have resulted in increased federal reimbursement for health care services, federal funding for telehealth services and electronic health records, more investments and research in value-based care, enhanced services for chronically and critically ill patients, and improved access and convenience of health care in home and community-based settings.

Rich is skilled and experienced in working with associations, healthcare providers, insurers, patient advocacy groups, corporations, universities, investment firms, health technology entrepreneurs, and public policy think tanks to promote innovation in health care through coalition partnerships, strategic planning, policy analyses, and national advocacy.

Stacy Tegan is a Program Director at TransCelerate Biopharma, Inc., a not-for-profit collaboration catalyzing the biopharmaceutical R&D community to drive innovation, simplify
clinical trials and converge clinical research with clinical care. In her current role she oversees efforts to digitize clinical trial protocols, increase the integration of EHRs into clinical research processes, and enable pragmatic trials to be conducted at the point of care, and serves as Co-Lead for Vulcan UDP (Utilizing the Digital Protocol) Project. She has 20+ years of experience improving regulatory and clinical processes, and expertise in project management, strategic planning, digitization, and change management.

Stacy is passionate about taking improving the community, with a history of volunteerism at the Drug Information
Association (DIA), youth organizations, and she currently serves on her local Environmental Advisory Council.

Steve Heard began his career in his own backyard of San Francisco during the early internet days. Sparked by a summer internship while still attending Hampshire College, he found himself in the thick of things working alongside the very developers that created the iconic AOL “You got mail!” experience and Disney’s first internet presence. From there he was instrumental in media, gaming, and internet startups, burgeoning in Silicon Valley and Boston. One of his most impactful, early roles was “Chief Nerd” at NPR’s Car Talk. But he gave up all the glamour when he joined old friends to become employee #1 at J2 Interactive, a then nascent professional health IT services organization.

Dr. Su Chen, MD, is a Clinical Science Principal at MITRE. She is an intrepid emergency medicine physician, computer scientist, and clinical informaticist with systems leadership experience in digital health innovation at the national scale. At MITRE, Su is the Chief
Clinician for MITRE’s health research moonshot project, which aims to leverage open technologies and standards to unlock the potential of real-world data to transform care and research.

She pioneered mCODE as the de facto standard for cancer data exchange while leading the HL7® CodeX™ FHIR® Accelerator, securing adoption by major EHRs and integration into federal agency initiatives (CMS, CDC, ASTP, VA). Prior to joining MITRE, Su served as Director of Clinical IT in a nationwide health system, Steward Health Care, and Chief Medical Information Officer and Urgent Care Medical Director of the Greater New Bedford Community Health Care Center.

Dr. Teresa Zayas Cabán is Assistant Director at the National Library of Medicine (NLM) and Senior Advisor within the Lister Hill National Center for Biomedical Communications at NLM.

Dr. Zayas Cabán was previously Chief Scientist at the Office of the National Coordinator for Health Information Technology (ONC) where she led ONC’s scientific efforts and activities. In that role she developed, established, or recommended scientific policy to the National Coordinator, directed ONC’s Precision Medicine Initiative activities, and provided oversight of ONC’s patient-centered outcomes research projects.

Prior to her position at ONC, Dr. Zayas Cabán was the Chief of Health IT Research and Acting Director of the Division of Health IT at the Agency for Healthcare Research and Quality (AHRQ). While at AHRQ, she set new directions for their funding opportunities and coordinated with federal partners, such as the National Science Foundation.

Before joining AHRQ, she served as a post-doctoral trainee in the computation and informatics in biology and medicine program at the University of Wisconsin-Madison. Dr. Zayas Cabán obtained her doctorate in industrial and systems engineering at the University of Wisconsin-Madison where she was a National Science Foundation graduate research fellow in industrial engineering.

Umit Topaloglu, PhD, FAMIA, is a clinical research informaticist specializing in artificial intelligence (AI) applications and privacy-preserving federated learning (FL) methodologies. His research integrates AI-driven semantic data frameworks, standard-based data collection, and advanced Natural Language Processing (NLP) techniques to develop interoperable clinical research solutions. Dr. Topaloglu's expertise encompasses creating and leading strategic roadmaps that leverage AI and federated learning within large-scale data-sharing networks, enterprise data governance, and data warehousing initiatives.

Currently, Dr. Topaloglu serves as Chief of the Clinical and Translational Informatics Branch at the National Cancer Institute (NCI), where he directs several AI and federated learning initiatives within NCI's clinical research programs, including Precision Medicine Initiatives, the Clinical Trials Reporting Program, and Real-World Data/Evidence (RWD/RWE) programs. He oversees the development of NCI’s Semantic Infrastructure—such as the Enterprise Vocabulary Service (EVS) and cancer Data Standards Repository (caDSR)—integrating AI and federated learning frameworks to enhance data interoperability, privacy, and research collaboration. Previously, Dr. Topaloglu held roles as Associate Director of the Center for Biomedical Informatics and co-Director of the Bioinformatics Shared Resource at Wake Forest University School of Medicine, where he remains adjunct faculty.

Yoshihiro Aoyagi is the Manager of the Department of Medical Information at the National Cancer Center Hospital East in Japan. He specializes in project management, data management, and the digital transformation of clinical trials. As a certified Project management Professional (PMP), he has led numerous initiatives to enhance operational efficiency and data integrity in clinical research.

He has played a pivotal role in developing advanced information systems, including remote Source Data Verification (SDV) and direct data capture from Electronic Medical Records (EMR), optimizing the utilization of iinformation resources within the hospital. In addition, he has conducted extensive research on leveraging Hospital Information System data to improve reliability and transparency.

Yoshihiro is an authorized instructor for CDISC CDASH, a global collaborator for OHDSI, and a member of the Operational Committee for HL7 Vulcan, contributing to international standards development. Prior to his current role, he worked as a clinical pharmacist specializing in drug information.